| Financial Year |
March 31 2023 |
| Monetary Funds |
328,498,221.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,554,193.00 |
| Accounts Receivable |
746,958,434.23 |
| Advances to Suppliers |
9,102,618.02 |
| Other Receivables |
37,974,736.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
424,839,068.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,771,470.50 |
| Total Current Assets |
1,564,439,761.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
69,061,372.07 |
| Investment Properties |
13,120,517.32 |
| Fixed Assetes |
413,805,513.16 |
| Under-construction Projects |
228,831.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
45,423,720.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,559,821.76 |
| Deferred Income Tax Assets |
12,991,942.67 |
| Other Non-Current Assets |
76,051,738.17 |
| Sub-Total of Non-Current Assets |
682,144,866.53 |
| Total Assets |
2,246,584,628.12 |
| Short-Term Loans |
132,087,388.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
134,497,807.74 |
| Accounts Payable |
330,942,290.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,392,744.33 |
| Taxes Payable |
17,625,367.70 |
| Interest Payable |
-- |
| Dividend Payable |
59,000.00 |
| Other payables |
7,424,245.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,143,336.70 |
| Other Current Liabilities |
7,006,695.07 |
| Sub-Total of Current Liabilities |
689,104,400.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,452,995.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,781,140.14 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
2,849,204.28 |
| Sub-Total of Non-Current Liabilities |
11,986,954.45 |
| Total Liabilities |
701,091,354.45 |
| Paid-In Capital(Or Share Stock) |
203,242,000.00 |
| Capital Surplus |
498,409,755.27 |
| Surplus Reserve |
101,621,000.00 |
| LESS:Treasury Stock |
50,100,493.41 |
| Undistributed Profits |
767,601,775.54 |
| Minority Stockholder's Interest |
-888,609.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,546,381,883.24 |
| Owner's Equity（Stockholder's Equity） |
1,545,493,273.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,246,584,628.12 |
